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Treatment of mice with 8-methoxypsoralen plus long-
wave UV radiation (UV A, 320-400 nm) decreased their 
response to contact sensitizers applied subsequently to 
unirradiated skin. This decreased reactivity exhibited a 
delayed time course, it affected the afferent but not the 
efferent phase of the reaction, and it was associated with 
the development of splenic suppressor cells. These sup-
pressor cells were antigen-specific T lymphocytes, and 
they prevented the induction, but not the elicitation, of 
contact hypersensitivity in recipient mice. In all of these 
characteristics, the decreased reactivity induced by 
treatment with psoralen plus UV A radiation (PUV A) 
resembled that produced by UV radiation of shorter 
wavelengths ( < 320 nm). These studies suggest that 
PUV A treatment may initiate the same sequence of cel-
lular events as does exposure to sunlamp (UVB, 280-320 
nm) radiation, leading to preferential activation of the 
suppressor cell pathway. 
Exposure of mice to UV radiation from FS40 sunlamps, which 
emit wavelengths predominantly in the UVB (280-320 nm) 
range, depresses their r esponse to contact allergens applied 
subsequently to unirradiated skin [1]. This decreased reactivity 
is accompanied by the appearance of antigen-specific suppres-
sor T lymphocytes (T, cells) in the spleens of mice exposed first 
to UV radiation and then to th e sensitizing a nt igen [2]. The 
induction of T s cells in UV -irradiated mice has been attribu ted 
to an alteration in the presentation of certain antigens by cells 
of macrophage lineage [1,3-6]. 
Recent studies addressing the question of how UV radiat ion 
induces. suppression of contact hypersensitivity (CHS) impli-
cated DNA as a possible target for the init ial photobiologic 
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Abbreviations: 
C': complement 
CHS: contact hypersensitivity 
DNFB: dinitrofluorobenzene 
LNC: lymph node cells 
8-MOP: 8-methoxypsoralen 
OXA: oxazolone = 4-ethoxymethylene-2-phenyl-oxazol-5-one 
PUVA: 8-MOP plus UVA radiation 
T, cells: suppressor T lymphocytes 
TNCB: trinitrochlorobenzene 
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event . Analysis of th e wavelength dependence of this UV radia -
tion-induced suppression demonstrated that the most effective 
wavelengths lie in th e range of 260-270 nm [7]. Since DNA is 
one of several molecular species in skin t;l>at strongly a bsorb 
radiat ion of these wavelengths, damage "to the DNA of partic-
ular target cells in the skin might be th e initiating event in the 
subsequent suppresf'ion of CHS. Our fu·st approach to testing 
this hypothesis was to select another agent that also produces 
DNA damage in th e skin and to determine wh eth er treatment 
with this agent would produce similar immunologic alterations. 
The chemical photosensitizer 8-methoxypsoralen (8-MOP) , in 
combination with long-wave UV radiation (UV A, 320-400 nm) , 
which is designated by the acronym PUVA, induces DNA 
damage and elicits many of th e same biologic responses in the 
skin of humans and la boratory a nimals as sunlamp irradiation. 
These include sunburn, m elanization, damage to Langerh ans 
cells, and probably even the induction of cancer [8-10]. Thus it 
was not unreasonable to suppose that PUV A treatment also 
might alter immunologic functions in a manner similar to that 
described for sunlamp irradiation. 
The pw-pose of this study was to determine whether treat-
ment of mice with PUV A produces systemic suppression of 
CHS, and, if so, whether th e cellular m echanisms are similar to 
those associated with suppression of CHS by UVB radiation. 
This issue is of addit ional interest because of the current 
widespread use of PUV A for the treatment of several common 
skin diseases in humans, notably psoriasis and vit iligo. For this 
reason also, it is important to identify any potential immuno-
logic alterations that may accompany PUVA treatment. 
MATERIALS AND METHODS 
Mice 
Specific-pathogen-free female mice of the inbred strains C3H/ HeN-
(MTV- ), BALB/ cAnN, and (C57BL/ 6N x C3H/ HeN) Fl hybrids 
(B6C3F1) were supplied by the NCI-Frederick Cancer Research Facil-
ity's Animal Production Area. The animals were 8- 12 weeks old at the 
start of an experiment, and within each experiment, the age of the 
animals did not vary by more than 1 week. The mice had free access to 
Purina mouse chow and chlorinated water (10- 12 ppm) and were 
housed in rooms where ambient light was automatically regulated on 
a 12-h light-dark cycle. 
PUVA Treatment 
8-MOP was administered by i.p. injection of 0.4 mg (Hoffmann-La 
Roche, Inc., Nutley, New Jersey) in 0.5 ml of a 2% gelatin solution. For 
treatment, the dorsal fur was removed from the mice with electric 
clippers; they were then given 8-MOP, and 30- 60 min later they were 
exposed to UVA radiation. The UVA radiation (> 320 nm) was deliv-
ered from a bank of 6 P_UV A fluorescent bulbs (Sylvania, Danvers, 
Massachusetts) filtered through a 0.05-mm sheet of Mylar to eliminate 
wavelengths in the UVB region (< 320 nm) [11]. The output of the 
filtered light source was measured with an IL 700 UV spectroradiometer 
system (International Light, Inc., Newburyport, Massachusetts), using 
a WBS350 filter and a SEE400 detector, which provides a measure of 
the i.rradiance for the integrated waveband between 320-400 nm. The 
i.rradiance at the level of the animals' backs averaged 5 W / m2 • During 
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the irradiation, the mice were placed in individual compartments on a 
shelf 20 em below the radiation source to prevent shielding by cage-
mates. Black electrical tape was used to shield the ears during the 
irradiation period. 
UVB Treatment 
The conditions of b·eatment of the animals with UVB radiation were 
identical to those described above for exposw·e to UVA radiation. UVB 
radiation was provided by a bank of 6 FS40 sunlamps (Westinghouse, 
Bloomfield, New J ersey). The energy output was measured with the 
IL 700 radiometer using a #PT171C UVB detector with a WB320 filter 
and an A127 quartz diffuser. Approximately 80% of the radiation 
emitted by this source is within the 280- to 340-nm wavelength range. 
The irradiance at the level of the animals' backs averaged 4.5 W / m2. 
Induction of Contact Hypersensitivity 
The method of Asherson and Ptak [12] was used to induce CHS. 
Briefly, the abdominal fur was removed from the mice with electric 
clippers; the ahdomen was then shaved with a razor blade to remove 
all traces of hair. This surface was painted with 50 j.tl of 5% trinitro-
chlorobenzene (TNCB) in acetone, 30 j.tl of 0.5% dinitrofluorobenzene 
(DNFB) in acetone, or 100 j.tl of 3% oxazolone (OXA) in ethanol. The 
mice were tested for CHS 5 or 6 days later by applying 5j.tl of 1% TNCB 
in acetone, 0.2% DNFB in acetone, or 3% OXA in olive oil to both 
surfaces of each ear. Ear thickness was measured with a spring-loaded 
micrometer (model 7309, Mitutoyo, Japan) before and 24 h after 
application of the challenge dose. The specific ear swelling was obtained 
by subtracting the amount of swelling produced in mice that were 
challenged on the ears but not sensitized. 
Preparation of Suppressor Cell Populations 
Cell suspensions were prepared by teasing spleens with forceps into 
RPMI 1640 medium. The cells were filtered through nylon gauze, 
washed, resuspended, and reftltered prior to counting. For unfraction-
ated preparations, this cell suspension was injected i.v. at a dose of 1 
X 10" viable nucleated cells per recipient. All cell suspensions injected 
contained > 80% viable cells, as determined by trypan blue staining. 
Plastic-adherent cells were removed by resuspending the cells in 
RPM! 1640 medium with 10% fetal bovine serum and plating for 1 h at 
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37°C on 150 rom-diameter tissue culture dishes (2 spleens per plate in 
15 ml of medium). Nonadherent cells were collected by rinsing with 
RPM! 1640. Approximately 60% of the cells were recovered; no change 
in the percentage ofT lymphocytes could be detected in the preparat ion 
after the adherence procedure, as determined by immunofluorescence 
staining. 
To remove T lymphocytes, the spleen cell suspensions were incu-
bated with monoclonal anti-Thy 1.2 serum (New England Nuclear, 
Boston, Massachusetts) at a dilution of 1:500 for 30 min at 4°C. The 
cells were then washed 3 times and incubated with rabbit complement 
(C'; Pel-Freeze, Rogers, Arkansas) at a dilution of 1:16 for 60 min at 
37°C. The cells were washed twice and then injected i.v. Control cells 
were incubated without antiserum, but with C'. In these experiments, 
the percentage of T lymphocytes in the spleen cell suspensions was 
reduced from approximately 40% to 50% (in the control group treated 
with C' only) to between 5% and 15% in the groups treated with 
antibody plus C' as measured by indirect immunofluorescence. The 
proportion of cells with surface lg increased following antibody plus C' 
treatment. The methods for these techniques have been published 
(13]. 
To test for suppressor cell activity, mice were injected with various 
spleen cell preparations and immediately contact-sensitized; they were 
challenged 6 days later. The percent suppression was calculated as 
follows: % suppression = 100(1-(A-B/C-B)], where the letters rep-
resent ear swelling in mice: A, sensitized and given spleen cells intra-
venously; B, not sensitized; and C, sensitized. 
RESULTS 
Systemic Suppression of CHS with P UV A 
A summary of several experiments with the same dose of 8-
MOP given i.p., different exposures to UV A radiation, and 
different strains of mice is presented in Table I. Either single or 
repeated treatments with PUV A reduced the CHS reaction to 
TNCB. Neither 8-MOP alone nor UVA radiation alone reduced 
CHS; furthermore, the background level of ear swelling in 
unsensitized mice was not affected by any of the treatments. In 
dose-response studies, it was determined that in the pigmented 
strains of mice (C3H- and B6C3Fl), a single 90-min exposure 
TABLE I. Suppression of CHS to TNCB by P UVA treatment 
Strain 
BALB/c" 
8-MOP" 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
UVA 
(kJ/m' ) 
22.5 
202.5 
202.5 
9 
18 
9 
18 
36 
36 
27 
UVB" 
-TNCB 
3.2 ± 1.4 
2.8 ± 0.4 
3.1 ± 2.3 
2.9 ± 1.6 
3.5 ± 1.9 
4.3 ± 0.9 
5.0 ± 0.5 
4.9 ± 0.5 
5.5 ± 0.5 
4.7 ± 0.6 
5.3 ± 0.4 
4.3 ± 0.6 
3.9 ± 0.5 
6.0 ± 0.5 
+ 4.9 ± 0.8 
5.5 ± 0.5 
2.1 ± 0.3 
+ 0.9 ± 0.2 
2.4 ± 0.2 
a 0.4 mg in 0.5 ml 2% gelatin was injected i.p. 30-60 min before UV A irradiation. 
• UVB radiation was given once at a total dose of 48.6 kJ /m2 • 
Ear swelling ± SEM 
(em X 10-") 
+TNCB A' 
11.4 ± 2.5 8.2 
7.0 ± 2.8 4.2 
14.8 ± 3.3 11.7 
12.1 ± 2.4 9.2 
11.8 ± 2.6 8.3 
14.7 ± 1.1 10.4 
12.7 ± 0.8 7.7 
19.6 ± 2.3 14.7 
21.3 ± 0.7 15.8 
13.4 ± 0.7 8.7 
9.1 ± 0.9 3.8 
8.5 ± 0.8 4.2 
12.3 ± 0.6 8.4 
16.9 ± 1.4 10.9 
7.4 ± 0.4 2.5 
12.5 ± 0.9 7.0 
3.5 ± 0.3 1.4 
2.1 ± 0.6 1.2 
8.4 ± 1.0 6.0 
c ll = mean of group sensitized with TNCB minus mean of unsensitized group. Five mice per group. 
d %8 = (1-(/l of test group + ll of untreated group)] X 100. 
%8" 
1 
49 
0 
0 
34 
51 
7 
0 
46 
40 
0 
0 
64 
77 
80 
' p = probability of no difference from untreated group, determined by Student's t-test. Minimum number of mice per group 
probabilities p < 0.05 are recorded. 
f Mice were treated 5 times/week for 3 weeks with PUV A and sensitized 24 h after last treatment. 
11 Mice were given a single PUV A treatment and sensitized 4- 7 days later. 
p ' 
<0.01 
< 0.001 
<0.001 
<0.02 
<0.01 
<0.001 
<0.001 
<0.001 
5. Only 
Aug.l983 SYSTEMIC SUPPRESSION OF CONTACT HYPERSENSITIVITY BY PUVA 89 
100 
Q) 80 
Vl 
c: 
0 
c. 
Vl 
Q) 60 a:: 
e 
c 
0 40 
c..> 
0 
-:!!. 0 20 
2 3 4 5 6 7 
Days Between UVR and Sensitization 
FIG 1. Time course of suppression 9f CHS following a single PUV A 
(e-e) or UVB (0-0 ) treatment. C~H- mice were injected with 0.4 
mg 8-MOP i.p. and exposed to 27 kJ / m2 UVA (PUVA) or exposed to 
48.6 kJ / m2 UVB radiation. On successive days thereafter 30 fLl of 0.5% 
DNFB in acetone was applied to the shaved abdomen of half of the 
mice in each group, and the ears of all the mice were tested 6 days 
later. Each point represents the mean of two separate experiments 
each of which contained 5 mice per group. Significant suppression was 
observed in both the PUV A- and UVB-treated groups from day 3 
onward. 
to UV A radiation (27 kJ /m2 ) in combination with 0.4 mg 8-
MOP administered i.p. produced approximately the same de-
gree of gross phototoxicity as a single 3-h exposure to FS40 
sunlamps (48.6 kJ/m2 UVB), i.e., necrosis of the skin along the 
dorsal ridge of the back about 1 week after the treatment. 
Because of the comparable phototoxicity produced by these 
regimens of UV radiation, these doses were used in all subse-
quent experiments. 
Previous studies in BALB/c mice [1] on the time course of 
the UVB radiation-induced suppression of CHS.demonstrated 
that several days must elapse between the irradiation and the 
application of the sensitizer in order for suppression to occur. 
As is illustrated in Fig 1, a similar pattern was observed in 
C3H- mice after PUV A or UVB radiation treatments. Sensiti-
zation of mice 24 h after UVB irradiation or PUV A treatment 
produced normal levels of reactivity. Minimal reactivity was 
induced when the sensitizing agent was applied between 3 and 
4 days after the irradiation, and it increased slowly thereafter. 
Effect of PUVA or UVB Radiation on Elicitation ofCHS 
We next investigated the stage of the CHS reaction that was 
affected by PUV A treatments or UVB irradiation. Two types 
of experiments were performed to determine whether suppres-
sion was occurring by means of an effect of these treatments on 
the elicitation phase of the reaction. In the first, draining lymph 
node cells (LNC) from DNFB-immunized mice were injected 
i.v. into animals that had been treated with PUVA or UVB 
radiation 4 days earlier (passive sensitization). The recipients 
were challenged by ear painting immediately, and ear swelling 
was measured 24 h later, As is shown in Table II, experiment 1, 
the reaction elicited in the passively sensitized animals was not 
reduced significantly by prior treatment with UVB radiation or 
PUV A. In contrast, however, mice treated with PUV A or UVB 
radiation that were actively sensitized 'Jy DNFB painting on 
day 4 exhibited significantly lower reactivity. 
In the second type of experiment, mice were fust sensitized 
with DNFB and then treated with UVB radiation or PUV A 
before elicitation of the reaction. Again, neither treatment 
reduced the CHS reaction in mice that were already sensitized 
to DNFB (Table II, experiment 2) . Control mice from the same 
UVB and PUV A treatment groups that were sensitized 5 days 
after these treatments exhibited only minimal reactivity. These 
experiments demonstrate that neither PUV A treatment nor 
UVB in-adiation affects the elicitation phase of the response, 
implying that an earlier step in the CHS reaction is impaired. 
Induction of Suppressor Cells 
Previous studies demonstrated that the inhibition of CHS by 
UVB radiation was accompanied by the appearance ofT. cells 
in the spleens of the irradiated mice [2]. To determine whether 
T . cells were also produced as a result of sensitization following 
PUV A treatment, the following experiment was carried out: 
Mice were treated with UVB radiation or PUV A, sensitized 4 
days later with DNFB, and tested on day 9 for reactivity to 
demonstrate that their response was impaired. On day 10, 
spleen cells were taken from these mice and injected i.v. into 
syngeneic recipients. The recipients were sensitized immedi-
ately with DNFB and tested 6 days later to see whether CHS 
had been induced. The results of a representative experiment 
are given in the upper portion of Table Ill. The spleen cell 
donors that were treated with PUV A or UVB before sensitiza-
tion with DNFB exhibited 68% and 96% suppression of CHS, 
respectively, compared with unirradiated control mice. Transfer 
of 108 spleen cells from the suppressed mice resulted in an 
TABLE II. Effect of PUVA or UVB radiation on elicitation of CHS 
to DNFB in. C3Ir mice 
Sensitization Elicitation 
Treatmene• Ear swell- Percent 
Agent Day" ing Day" suppression" 
±SEM' 
Experiment I 
UVB Immune LNC' +4 8.3 ± 0.9 +5 0 
UVB 1.0 ± 0.3 +5 
PUVA Immune LNC +4 7.3 ± 0.5 +5 14 
PUVA 2.3 ± 0.5 +5 
None Immune LNC +4 7.8 ± 0.9 +5 
None 2.0 ± 0.4 +5 
UVB DNFB' +4 4.3 ± 0.3 +I2 76' 
UVB 2.8 ± 0.4 +12 
PUVA DNFB +4 5.2 ± 0.7 +12 58" 
PUVA 2.6 ± 0.2 +12 
None DNFB +4 9.7 ± 0.5 +12 
None 3.5 ± 0.3 +12 
Experiment 2 
UVB DNFB -5 7.2 ± 0.9 +6 0 
UVB 2.9 ± 0.7 +6 
PUVA DNFB -5 6.7 ± 0.8 +6 0 
PUVA 3.3 ± 0.5 +6 
None DNFB -5 6.3 ± 0.5 +6 
None 3.3 ± 0.6 +6 
UVB DNFB +5 2.1 ± 0.4 +13 93' 
UVB 1.6 ± 0.5 +I3 
PUVA DNFB +5 3.5 ± 0.7 +13 87" 
PUVA 2.6 ± 0.3 +13 
None DNFB +5 10.0 ± l.l +13 
None 3.0 ± 0.4 +13 
" UVB = I 3-h exposure(= 48.6 kJ / m2); PUV A = 0.4 mg 8-MOP i.p. + 90 min 
(27 kJ /m2 ) UVA given on day 0. 
' Number of days after initial treatment. 
' Mean ± SEM (em X 10-a) of 5 mice challenged 24 h earlier with DNFB on 
the ears. 
"%S = [1-(.:'. of test group + .:'.of untreated group)] X 100. 
' Immune LNC = 1.5 X 10' draining LNC from mice sensitized 4 days earlier 
with 30 jJl of 0.5% DNFB were injected i.v. Mice receiving cells were challenged 
immediately after injection. 
' DNFB = 30 jJl of 0.5% DNFB in acetone. 
• p < 0.001 vs uni.rradiated, DNFB-sensitized control group, as determined by 
Student's t-test. 
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impaired response in the recipient animals, indicating that 
suppressor cells were present in the donor spleens. No signifi-
cant suppression was transferred with spleen cells from mice 
treated with PUV A or UVB radiation that were not sensitized 
with DNFB or with spleen cells from unirradiated sensitized or 
unsensitized mice. The lower portion of Table III summarizes 
the results of 5 independent experiments of this kind, indicating 
that suppressor cells can be detected in the spleens of PUVA-
treated or UVB-irradiated mice after sensitization with DNFB. 
Separations of the spleen cells were carried out to determine 
whether the suppressor cells induced in PUV A-treated mice 
belonged to the T-lymphocyte subpopulation, like those in-
duced in UVB-irradiated animals [2]. Removal of the adherent 
spleen cells by incubation on plastic culture dishes did not 
decrease the suppressive activity of the cells from either the 
PUV A-treated or the UVB-irradiated group (Fig 2A). Reducing 
TABLE III. Transfer of suppression with spleen cells 
Treatment of spleen cell do-
nors" (%S) 1' 
Representative experiment 
PUVA + DNFB (68) 
PUVA 
UVB + DNFB (96) 
UVB 
None+ DNFB 
None 
No cells 
Totals from 5 separate ex-
periments' 
t. Ear swelling 
(em x JO-"r 
5.3 
11.0 
5.2 
14.7 
9.8 
16.3 
13.1 
Percent 
suppression(' p•' 
60 <0.001 
16 
60 <0.001 
0 
25 
0 
PUVA + DNFB (56.2 ± 49.6 ± 6.7 <0.01 
5.2) 
UVB + DNFB (68.8 ± 55.6 ± 5.7 <0.01 
8.7) 
None + DNFB 15.6 ± 4.8 
"UVB = 48.6 kJ /m.2; PUVA = 0.4 mg 8-MOP i.p. and 27 kJ/m2 
UV A. Mice were sensitized with 30 J.Ll of 0.5% DNFB 4 days after 
treatment. Spleen cells were transferred 6 days after sensitization. 
" %S = [1-(.:l of test group + £l of untreated group)] X 100, exhibited 
by the donor mice prior to transfer of their spleen cells. 
cAll recipients (5 mice per group) were sensitized with 30 J.Ll of 0.5% 
DNFB after i.v. injection of 1 X 108 spleen cells from the donor mice. 
£lear swelling = mean swelling in sensitized group minus mean swelling 
in unsensitized mice. 
"Percent suppression = [1-(.:l of test group + £l of no cell group)] x 
100. 
c p = probability of no difference from group that did not receive 
cells, determined by Student's t-test. Only probabilities p < 0.05 are 
recorded. 
'Numbers represent mean± SE of the % suppression obtained in 5 
separate experiments. 
Treatment Treatment of Cells 
of Donors 
None { Nonadherent 
Unfractionated 
PUVA { Nonadherent Unfractionated 
UVB { Nonadherent 
UntractioE:"~ated 
100 
A % Control Response 
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the number ofT lymphocytes in the preparation by incubation 
of the cells with monoclonal anti-Thy 1.2 antibody and C' 
removed the suppressive activity from both PUV A-treated and 
UVB-irradiated groups (Fig 2B). The spleen cell preparations 
treated with C' alone contained 40-50% T lymphocytes; those 
treated with antibody plus C' contained 5-15% T lymphocytes. 
Each experiment was performed twice with similar results. 
These results imply that T lymphocytes in the spleen cell 
preparations are essential for the suppression of CHS in the 
recipient mice. 
To determine which portion of the CHS reaction was affected 
by the suppressor cells, these cells were injected either imme-
diately before sensitization or immediately before challenge of 
presensitized mice. As is shown in Table IV, the suppressor 
cells from the UVB-irradiated or the PUVA-treated groups did 
not affect the elicitation of the reaction in previously sensitized 
mice. In contrast, suppressor cells from both groups prevented 
the induction of CHS in mice painted with DNFB after injection 
of the suppressor cells. 
Results of tests of the antigenic specificity of the suppressor 
cells are summarized in Table V. Transfer of DNFB-induced 
suppressor cells from mice treated with PUV A or UVB radia-
tion inhibited sensitization of the recipient mice with DNFB, 
but not with OXA. In the reciprocal experiment, sensitization 
of the treated mice with OXA-induced suppressor cells affected 
the response of the recipients to OXA, but not to DNFB. 
DISCUSSION 
Our studies demonstrate that PUV A treatment of mice can 
suppress CHS reactions much as UVB radiation does, i.e., by a 
delayed time course after irradiation, inhibition of the afferent 
arm of the CHS reaction, and induction of antigen-specific T. 
cells. These results suggest that UVB irradiation and PUV A 
treatment might initiate the same sequence of cellular events, 
which culminates in activation of the suppressor cell pathway. 
There is some evidence that this sequence of events involves an 
alteration in the antigen-processing or antigen-presenting activ-
ity of splenic macrophages in UVB-irradiated animals [1,4], but 
this possibility remains to be tested in PUV A-treated mice. 
Also, the induction of the suppressor cell pathway in UVB-
irradiated animals is selective for certain antigens. For example, 
although the immune response to contact allergens is impaired 
in UV-irradiated mice, these animals exhibit normal reactivity 
to alloantigens [14,15] and produce normal amounts of antibody 
to sheep erythrocytes and polyvinylpynolidone [14,16]. 
Whether PUVA-treated mice show a similar pattern of immune 
responsiveness also remains to be determined. Nonetheless, the 
results presented here are consistent with the hypothesis that 
the same target molecule in skin may serve as the initiator of 
immunosuppression induced by either UVB radiation or PUV A 
treatment. 
Treatment Treatment of Cells 
of Donors l Anti-theta+ C · 
None C' control 
Unfractionated 
l Anti-theta+ C' 
PUVA C ' control 
Unfractionated 
\Anti-theta+ C • 
UVB C ' control 
Unfractlonated 
B % Control Response 
FIG 2. Effect of fractionation of donor spleen cells on their suppressive activity by adherence to plastic cultw·e dishes (A) and by T lymphocyte 
deletion (B). 
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TABLE IV. Suppressor cells do not affect elicitation of CHS 
Recipients sensitized 
Six days before cell transfer 
Treatment of spleen 
cell donors" (%S) • 
PUV A + DNFB (56) 
UVB + DNFB (71) 
None + DNFB 
No cells 
1!. Ear swelling (em x 10- ') ' 
14.1 
14.3 
12.4 
13.6 
Percent 
suppressiond 
0 
0 
5 
p ' 
Immediately after cell transfer PUV A + DNFB (56) 2.2 63 <0.001 
UVB + DNFB (71) 3.8 36 <0.01 
None+ DNFB 9.9 0 
No cells 5.9 
• UVB = 48.6 kJ / m2 ; PUVA = 0.4 mg 8-MOP i.p. and 27 kJ / m2 UVA. Mice were sensitized with 30 pl of 0.5% DNFB 4 days after treatment. 
Spleen cells were transferred 6 days after sensitization. 
• %S = [1-(~ of test group+~ of untreated group)] X 100, exhibited by the donor mice prior to transfer of their spleen cells. . 
' All recipients (5 mice per group) were sensitized with 30 1LI of 0.5% DNFB after i.v. injection of 1 X 108 spleen cells from the donor mice. ~Ear 
swelling = mean swelling in sensitized group minus mean swelling in unsensitized mice. 
d Percent suppression= [1-(~ of test group+ ~of no cell group)] x 100. 
' p = probability of no difference from group that did not receive cells, determined by Student's t-test. Only probabilities p < 0.05 are recorded. 
TABLE V. Specificity of suppressor cells 
Treatment of spleen 
cell donors" (%S)' 
PUV A + DNFB (66) 
UVB + DNFB (57) 
None+ DNFB 
No cells 
PUV A + OXA (37) 
UVB + OXA (93) 
None + OXA 
No cells 
1!. Ear swelling (em x 10-")' 
6.0 
4.1 
9.6 
10.8 
9.4 
8.5 
9.7 
8.1 
DNFB 
Percent 
suppressiontl 
44 
62 
62 
0 
0 
0 
Recipients' sensitized with 
p 1!. Ear swelling (em x 10- 3) 
<0.03 17.3 
< 0.001 18.3 
16.2 
18.1 
9.7 
10.0 
13.8 
13.6 
OXA 
Percent 
suppression 
4 
0 
10 
26 
29 
0 
p 
< 0.05 
<0.05 
" UVB = 48.6 kJ / m2 ; PUVA = 0.4 mg 8-MOP i.p. and 27 kJ / m2 UVA. Mice were sensitized 4 days after treatment with 30 pl of 0.5% DNFB in 
acetone or 100 11! of 3% OXA in ethanoL Spleen cells were transferred 6 days after sensitization. 
• %S = [1-(~ of test group+ ~of untreated group)] X 100, exhibited by the donor mice prior to transfer of t heir spleen cells. 
c All recipients (5 mice per group) were sensit ized as above, immediately after i.v. injection of 1 X 108 spleen cells from the donor mice.~ Ear 
swelling = mean swelling in sensitized group minus mean swelling in unsensitized mice. 
d P ercent suppression= [1-(~ of test group+~ of no cell group)] x 100. 
One possible candidate for such a target molecule is DNA, 
since both UVB radiation and PUVA induce DNA damage. 8-
MOP intercalates into DNA and absorbs long-wave UV radia-
tion (> 300 nm). This energy is utilized to form covalent bonds 
between the psoralen and the DNA strands, resulting in the 
formation ofmonoadducts and cross-links in the DNA. Like the 
thymine dimers produce in DNA by the shorter UV wave-
lengths, these lesions can be removed by cellular repair mech-
anisms, but in sufficient quantity they interfere with DNA 
replication [17] . With both PUV A and UVB radiation, the 
formation of DNA damage in vivo is limited by the depth of 
penetration of the radiation. The penetration of UV radiation 
increases somewhat with longer wavelengths [18]; however, the 
DNA damage that occurs following systemic administration of 
8-MOP and UVA radiation or of UVB radiation alone still is 
confined mainly to the skin and would not be expected to occur 
in cells of the deeper internal organs. Although DNA is a likely 
candidate for the target of PUV A- and UVB radiation-induced 
immunosuppression based on the action spectrum for this effect 
[7], other possibilities are not ruled out by these studies. Both 
treatments are likely to cause alterations of ot her cellular 
constituents in addition to inducing DNA damage, and it is 
possible that another, yet unidentified, target may be respon-
sible for initiating the immunosuppressive effects. Additional 
studies with other photosensitizing and DNA-damaging agents 
are required to resolve this point. 
Previous studies by others have examined the effects of 
PUVA treatment on the induction and/ or elicitation of CHS 
reactions at the site of irradiation. Using C3H mice, Lynch et 
al [9] found that topical 8-MOP plus a 60-min UVA exposure 
given for 7 days resulted in a reduction of CHS to DNFB that 
was applied on the treated site for sensitization. Similarly, 
Horio and Okamoto [19] reported that in guinea pigs, sensiti-
zation through PUV A-treated skin also reduces the CHS reac-
tion, although this was not found in a previous study by Morison 
et al [20]. Other studies have suggested that PUV A treatment 
of guinea pigs at the site of elicitation of CHS reduces the 
reaction [20,21], but it is not clear from these experiments 
whether PUV A treatment was affecting the afferent or t he 
efferent phase of the reaction, or both. 
In our experiments, PUV A treatment was shown to affect the 
afferent phase of the reaction by means of a systemic alteration, 
since neither the sensitization nor the elicitation sites were 
exposed to the radiation. The doses of PUV A and UVB used in 
these studies generally were sufficient to produce gross photo-
toxicity, particularly in the experiments in which a single treat-
ment was employed. In fact, the PUV A doses were selected to 
produce approximately the same degree ofphototoxicity as that 
produced in the mice by a 3-h exposure to the UVB radiation 
source. Sufficient damage was produced by this treatment to 
result eventually in necrosis and scarring of th e skin along the 
dorsal ridge. It might be argued that the immunosuppression 
we observed was due to general debilitation as a consequence 
of an acute inflammatory response. However, previous studies 
addressing this point have established that there is no correla-
tion between the degree of skin damage and the amount of 
suppression of CHS induced by UVB radiation. For example, 
fractionating the dose of radiation into small increments pro-
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duces less skin damage than a single treatment with the same 
total dose, yet both produce the same level of suppression of 
CHS [2]. In addition, monochromatic 270-nm UV radiation 
produces no visible alterations in mouse skin at doses that are, 
nonetheless, highly immunosuppressive [22]. Although such a 
separation between skin damage and suppression of CHS has 
not been made for PUV A treatment, the selectivity of its effect 
for the afferent portion of the CHS response suggests that it is 
not producing generalized immunologic debilitation. 
It is clear that PUV A treatment, like UVB irradiation, can 
cause systemic suppression of CHS reactions in the mouse, 
which is associated with the production of antigen-specific T s 
cells. At present, both of these treatments are widely used in 
the therapy of skin diseases in humans. Both treatments have 
beneficial therapeutic effects, but they may also be associated 
with the adverse effect of increasing the risk of skin cancer 
[10] . The mechanisms of both the therapeutic and the adverse 
effects of these treatments may involve alterations of immune 
function; in fact, there is some evidence that PUV A treatment 
can alter immune reactivity in humans. Suppression of CHS to 
DNCB has been reported in patients with psoriasis treated with 
PUV A therapy [23,24]; however, there is no information on the 
specificity of this effect or its mechanism, nor is it known 
whether UVB phototherapy has a similar effect. Further studies 
in suitable animal models and in humans are necessary to 
explore the possibility that immunologic factors are involved in 
the responses to phototherapy. 
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